Alto Neuroscience, Inc.: insider trading
42 trades by 9 directors, officers and 10% owners since 2024, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$5.6 M
8 sales by 2 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$5.6 M
8 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (9)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | 0 | — | $2.1 M | |
| Nicholas Conrad SmithPRESIDENT AND CFO | 79,060 | — | $3.6 M | |
| Amit EtkinPRESIDENT AND CEO, Director | 833,949 | — | — | |
| Adam SavitzCHIEF MEDICAL OFFICER | — | — | — | |
| Alpha Wave Global, LP10% owner | — | — | — | |
| Apeiron Investment Group Ltd.See Remarks | 251,881 | — | — | |
| Chen Po Yu (Jeff)Director | 47,709 | — | — | |
| Christopher Nixon CoxDirector | — | — | — | |
| Gwill YorkDirector | 23,917 | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Option exercise10b5-1 plan | +2,896 | $2.350 | $7 K | 2,896 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Sell10b5-1 plan | -2,896 | $26.48 | $77 K | 0 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Option exercise10b5-1 plan | +2,104 | $2.350 | $5 K | 2,104 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Sell10b5-1 plan | -2,104 | $26.82 | $56 K | 0 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Option exercise10b5-1 plan | +17,729 | $2.350 | $42 K | 17,729 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Option exercise10b5-1 plan | +44,271 | $2.350 | $104 K | 62,000 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Option exercise10b5-1 plan | +8,000 | $2.350 | $19 K | 70,000 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Sell10b5-1 plan | -56,410 | $27.46 | $1.5 M | 13,590 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Sell10b5-1 plan | -10,895 | $28.43 | $310 K | 2,695 | Form 4 |
| filed | Michael Conick Hanley Jr.CHIEF OPERATING OFFICER | Sell10b5-1 plan | -2,695 | $29.09 | $78 K | 0 | Form 4 |
| filed | Nicholas Conrad SmithPRESIDENT AND CFO | Option exercise | +55,000 | $2.320 | $128 K | 79,060 | Form 4 |
| filed | Nicholas Conrad SmithPRESIDENT AND CFO | Option exercise10b5-1 plan | +24,056 | $2.350 | $57 K | 48,116 | Form 4 |
| filed | Nicholas Conrad SmithPRESIDENT AND CFO | Sell10b5-1 plan | -23,170 | $25.78 | $597 K | 24,946 | Form 4 |
| filed | Nicholas Conrad SmithPRESIDENT AND CFO | Sell10b5-1 plan | -886 | $26.87 | $24 K | 24,060 | Form 4 |
| filed | Nicholas Conrad SmithPRESIDENT AND CFO | Option exercise10b5-1 plan | +56,455 | $2.350 | $133 K | 80,515 | Form 4 |
| filed | Nicholas Conrad SmithPRESIDENT AND CFO | Option exercise10b5-1 plan | +54,375 | $2.350 | $128 K | 134,890 | Form 4 |
| filed | Nicholas Conrad SmithPRESIDENT AND CFO | Sell10b5-1 plan | -110,830 | $26.58 | $2.9 M | 24,060 | Form 4 |
| filed | Amit EtkinPRESIDENT AND CEO, Director | Gift | -400,000 | — | — | 833,949 | Form 4 |
| filed | Amit EtkinPRESIDENT AND CEO, Director | Shares withheld for tax | -6,227 | $19.69 | $123 K | 1.23 M | Form 4 |
| filed | Nicholas Conrad SmithCHIEF FINANCIAL OFFICER & CBO | Shares withheld for tax | -2,806 | $19.69 | $55 K | 24,060 | Form 4 |
| filed | Adam SavitzCHIEF MEDICAL OFFICER | Buyindirect | +2,931 | $13.22 | $39 K | 39,851 | Form 4 |
| filed | Adam SavitzCHIEF MEDICAL OFFICER | Buyindirect | +10,681 | $12.53 | $134 K | 35,532 | Form 4 |
| filed | Adam SavitzCHIEF MEDICAL OFFICER | Buyindirect | +1,388 | $13.15 | $18 K | 36,920 | Form 4 |
| filed | Nicholas Conrad SmithCHIEF FINANCIAL OFFICER | Buy | +1,600 | $15.80 | $25 K | 22,316 | Form 4 |
| filed | Nicholas Conrad SmithCHIEF FINANCIAL OFFICER | Buy | +4,550 | $16.56 | $75 K | 26,866 | Form 4 |
| filed | Amit EtkinPRESIDENT AND CEO, Director | Grant or award | +34,711 | — | — | 1.24 M | Form 4 |
| filed | Nicholas Conrad SmithCHIEF FINANCIAL OFFICER | Grant or award | +19,153 | — | — | 20,716 | Form 4 |
| filed | Apeiron Investment Group Ltd.See Remarks | Conversion | +251,881 | — | — | 251,881 | Form 4 |
| filed | Apeiron Investment Group Ltd.See Remarks | Conversionindirect | +674,658 | — | — | 674,658 | Form 4 |
| filed | Alpha Wave Global, LP10% owner | Conversionindirect | +1.96 M | — | — | 1.96 M | Form 4 |
| filed | Alpha Wave Global, LP10% owner | Conversionindirect | +1.14 M | — | — | 3.11 M | Form 4 |
| filed | Alpha Wave Global, LP10% owner | Buyindirect | +600,000 | $16.00 | $9.6 M | 3.71 M | Form 4 |
| filed | Nicholas Conrad SmithCHIEF FINANCIAL OFFICER | Buy | +1,563 | $16.00 | $25 K | 1,563 | Form 4 |
| filed | Amit EtkinPRESIDENT AND CEO, Director | Conversion | +11,777 | — | — | 1.20 M | Form 4 |
| filed | Chen Po Yu (Jeff)Director | Conversion | +39,259 | — | — | 39,259 | Form 4 |
| filed | Gwill YorkDirector | Conversion | +23,917 | — | — | 23,917 | Form 4 |
| filed | Adam SavitzCHIEF MEDICAL OFFICER | Conversionindirect | +7,851 | — | — | 7,851 | Form 4 |
| filed | Christopher Nixon CoxDirector | Conversionindirect | +588,898 | — | — | 588,898 | Form 4 |
| filed | Amit EtkinPRESIDENT AND CEO, Director | Buy | +3,125 | $16.00 | $50 K | 1.21 M | Form 4 |
| filed | Christopher Nixon CoxDirector | Conversionindirect | +126,755 | — | — | 715,653 | Form 4 |
| filed | Chen Po Yu (Jeff)Director | Conversion | +8,450 | — | — | 47,709 | Form 4 |
| filed | Adam SavitzCHIEF MEDICAL OFFICER | Buyindirect | +17,000 | $16.00 | $272 K | 24,851 | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice